Lyphe Group is a UK-based company operating in the medical cannabis industry. It is focused on the distribution and supply of medical cannabis products to patients. The company has established partnerships with global suppliers, enabling it to source and distribute medical cannabis from various regions, including Jamaica. In September 2023, Lyphe Group announced an exclusive partnership with Cronos Australia Limited, allowing it to distribute its products globally. Additionally, the company aimed to acquire Materia, a move expected to create a new European cannabis powerhouse. Lyphe Group has implemented strategies to consolidate its supply chain and achieve operational efficiencies.
Key customers and partnerships
Lyphe Group and Boveda INC. forged a partnership in September 2023 to cater to UK medical cannabis patients. The company also secured an exclusive deal with Cronos Australia Limited in 2023 to distribute its products globally. Furthermore, Lyphe Group signed an agreement to acquire Materia in 2023, with the aim of creating a new European cannabis powerhouse.
By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.